New Insights on Skin Sensitization Assessment: Essential Oils and Medical Devices
Join our upcoming webinar, where guest speakers from dōTERRA and Risk Science Consortium will share insights and case studies on the use of NAMs for skin sensitization assessment of Essential Oils and Medical Devices.
SenzaGen’s expert, Dr. Andy Forreryd, will also present the latest GARD® data from our research and industry collaborations.
If you missed SenzaGen’s poster presentations and scientific session at this year’s SOT in Orlando, this is your chance to catch up!
Key takeaways
- New GARD® data on Natural Extracts and Potency Assessment.
- Regulatory update Medical Devices (ISO 10993-10).
- User Cases from Clarins, dōTERRA, Unilever and more.
Speakers and Agenda
New GARD® Data on Natural Extracts, Medical Devices and Potency Assessment
Andy Forreryd, PhD
Scientific Liaison Manager @ SenzaGen
- Expert in in vitro assay development, genomics, and machine learning.
- Co-developer of the GARD®skin assay (OECD TG 442E).
- Active member of the ISO/TC 194/WG 8 on irritation and sensitization and OECD expert group on respiratory sensitization.
A Comparative Analysis of Human, Murine, and GARD®skin Dose-Response Skin Sensitization Thresholds for Essential Oils
Joe Dawson
Product Safety Manager @ dōTERRA International
- Manages the product safety team at dōTERRA International.
- 10 years of experience working as a research scientist in the natural products and cosmetics industries.
- Areas of expertise include literature review, risk assessment, and scientific claim substantiation.
They Promised Us Flying Cars: the Use of NAMs for the Safety Assessment of Medical Devices
Ron Brown
Toxicologist @ Risk Science Consortium (Former FDA Scientist)
- Toxicologist with 35 years of experience in regulatory toxicology and risk assessment.
- Former FDA reviewer with 25 years of experiences.
- Founding member and former President of the Medical Device and Combination Products Specialty Section of the Society of Toxicology and former President of the Dose-Response Specialty Section of the Society for Risk Analysis.
